← Back to Search

Behavioural Intervention

arm 2 for Post-COVID Syndrome

N/A
Recruiting
Led By Farha Ikramuddin, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial aims to study breathing difficulties in patients with long-term COVID-19 symptoms, which can cause shortness of breath, chest tightness, and fatigue. The study will use physical therapy to address

Who is the study for?
This trial is for individuals experiencing diaphragmatic dysfunction after COVID-19, which includes symptoms like shortness of breath and fatigue. Participants should have a history of COVID-19 and be facing ongoing respiratory issues.Check my eligibility
What is being tested?
The study tests two approaches to treat post-COVID diaphragmatic dysfunction: a specific Diaphragmatic Breathing (DB) program with manipulation techniques versus traditional care methods. The goal is to see which method better improves breathing, reduces fatigue, and enhances quality of life.See study design
What are the potential side effects?
Since the interventions involve physical therapy exercises rather than medication, side effects may include muscle soreness or discomfort during the exercises but are generally minimal compared to drug treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6-minute walk test (6MWT)
Secondary outcome measures
FACIT fatigue scale 's Fatigue score
GAD7: Generalized anxiety disorder 7-item
Modified Borg dyspnea scale
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: arm 2Experimental Treatment1 Intervention
participants randomize to diaphragmatic breathing (DB) program
Group II: arm 1Active Control1 Intervention
Participants randomized to usual care

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,951 Total Patients Enrolled
Farha Ikramuddin, MDPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"According to clinicaltrials.gov, this investigation is actively seeking participants. The trial was initially published on March 1st, 2024, and the most recent update was made on March 22nd of the same year."

Answered by AI

What is the current patient population enrolled in this clinical trial?

"Indeed, information from clinicaltrials.gov indicates that this investigation is actively seeking volunteers. Initially shared on March 1st, 2024, and last revised on March 22nd, 2024, the trial aims to enlist a total of 24 participants at one designated site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Diaphragmatic Breathing Exercises for Post-COVID-19 Diaphragmatic Dysfunction (DD)
2024. "Diaphragmatic Breathing Exercises for Post-COVID-19 Diaphragmatic Dysfunction (DD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06330376.
All > Paid Studies Minneapolis
~8 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top